Abstract: The invention relates to provide a fermented milk product includes angiogenin and/or angiogenin hydrolysate in an amount of 0.9 mg/100 g to 150 mg/100 g, and lactoperoxidase and/or lactoperoxidase hydrolysate in the mass ratio to the angiogenin and/or angiogenin hydrolysate of 0.3 to 23.

Abstract: A providing device according to the present application includes a detecting unit and a providing unit. The detecting unit detects a function, from among functions used for communication with an authentication server that authenticates the identity of a user by verifying a signature of authentication result information that is information created by adding the signature using a predetermined key to an authentication result obtained by an authentication device that performs personal authentication on the user and that is information processed by a specific authentication procedure, that is not held by a terminal device that is used by the user. The providing unit provides the function detected by the detecting unit to the terminal device that is used by the user.

Abstract: The present invention reduces the labor required for setting VLAN information in the ports of the communication nodes in a centralized-control-type communication system. A control apparatus includes: a connection detection unit configured to detect connection of a terminal or a virtual machine to a control target communication node; a first VLAN information determination unit configured to determine VLAN information that is set in a port of the communication node, the port having been connected to the terminal or the virtual machine, on the basis of a virtual network to which the detected terminal or virtual machine belongs; and a VLAN information setting unit configured to set the determined VLAN information in the port.

Abstract: A switch operation mechanism includes: a knob configured to be rotatable about a first rotation axis; a rotor configured to be rotatable about a second rotation axis; a first transmission mechanism configured to transmit rotation of the knob to the rotor and including a slide mechanism configured to allow displacement of the knob in a first direction intersecting with the second rotation axis; and a second transmission mechanism configured to convert the displacement of the knob in the first direction into an operation of a switch.

Abstract: This swallowing training apparatus includes: a respiration detection part configured to detect a respiratory motion of a subject; and a controller. The controller is configured to: provide a trigger for swallowing induction to the subject on the basis of a detection result from the respiration detection part; detect that swallowing was performed by the subject; determine whether or not the detected swallowing was at an appropriate timing with respect to the respiratory motion; and output, to outside, information indicating a result of the determination.

Abstract: A compound of the following general Formula [Ib]: wherein each symbol is the same as defined in the description; or a pharmaceutically acceptable salt thereof.

Abstract: A generation device according to the present application includes a storage unit and a generation unit. The storage unit stores information regarding an authentication module that carries out the authentication based on a result of the verification between registration data registered in advance and predetermined input data. The generation unit controls the generation of authentication result information which is information generated from the verification result acquired from the authentication module while serving as information to be processed through a specific authentication procedure used between the generation unit and an authentication server that carries out the personal authentication of a user using the authentication module.

Abstract: A state diagnostic device collects a usage state and diagnostic data of components, and selects, from the collected diagnostic data, at least one of diagnostic data obtained in a state where the usage state of the components is a truly normal state and diagnostic data obtained in a state where the usage state of the components is a truly abnormal state. The selected diagnostic data is defined as master data. A diagnosis result obtained by diagnosing the master data based on a current diagnostic model is compared with a diagnosis result obtained by diagnosing the master data based on a new diagnostic model, and whether the current diagnostic model is consistent with the new diagnostic model is determined. When the consistency is satisfied, the diagnostic model is updated from the current diagnostic model to the new diagnostic model.

Abstract: A diagnostic device diagnoses a state of a test object. The diagnostic device includes a physical model base diagnosis unit, a mathematical model base diagnosis unit, a model update necessity determination unit, and an update notification unit. The physical model base diagnosis unit is configured to perform the diagnosis using a feature quantity. The mathematical model base diagnosis unit is configured to perform the diagnosis using a machine learning model. The model update necessity determination unit is configured such that if diagnostic results by the physical model base diagnosis unit and the mathematical model base diagnosis unit differ, the model update necessity determination unit determines that at least one of a physical model or a mathematical model is necessary to be updated. The update notification unit is configured such that if the model update necessity determination unit determines that the update is necessary, the update notification unit notifies it.

Abstract: An object of the present invention is to provide a safety sensation-improving agent that can improve dulled peripheral sensations through daily ingestion or application to the skin. Another object of the present invention is to provide a sensation-improving food, beverage, feed, or cosmetics that can improve dulled peripheral sensations through oral ingestion or application to the skin. A sensation-improving agent containing a milk-derived protein and/or a hydrolysate therefrom as an active ingredient is provided. The milk-derived protein and/or the hydrolysate therefrom can be orally ingested or applied direct to the skin to improve dulled sensations, particularly peripheral sensations, and be formed into a sensation-improving food, beverage, feed, or cosmetics.

Abstract: A weighing, cutting and arranging system according to the present invention has a feeding section in which multiple rows of band-like dough are fed; a weighing and cutting section in which the dough of each row is cut so as to have a predetermined weight; and a discharging section in which cut doughs of the multiple rows are discharged in a single line. Each row of the weighing and cutting section has a shorter upstream conveyor with a weighing function, a longer downstream conveyor with a weighing function disposed downstream of the upstream conveyor, and a cutting device disposed upstream of and adjacent to the upstream conveyor. One of the multiple rows is defined as a reference row. After the cut doughs of the all rows are stopped at outlets of the respective downstream conveyors, the cut dough of the reference row is discharged.

Abstract: A spectacle lens manufacturing system includes resin material filling means which fills a lens mold with a lens material (heat-curable resin material), and at least a portion of the lens mold is formed by a three-dimensional printer. The lens mold includes a front lens mold having a rear surface that defines a front surface of a spectacle lens, a rear lens mold having a front surface that defines a rear surface of the spectacle lens, and a side peripheral lens mold having an inner surface that defines a side periphery of the spectacle lens. The side peripheral lens mold is formed by the three-dimensional printer.

Abstract: A spectacle lens manufacturing system includes resin material filling means which fills a lens mold with a lens material (heat-curable resin material), the lens mold includes a rear lens mold having a front surface that defines a rear surface of a spectacle lens, the rear lens mold has a rear lens mold base body, a three-dimensional printer which adds a aspherical surface addition portion to a front surface of the rear lens mold base body is provided, and a front surface of the rear lens mold is the front surface of the rear lens mold base body, to which the aspherical surface addition portion is added.

Abstract: A dysphagia treatment device includes: a current application unit configured to be attached to a target portion of a treated person in order to percutaneously apply current to a biological tissue of the neck including superior laryngeal nerve of the treated person; a control unit configured to control the current application unit such that percutaneous stimulation caused by an interference wave or a pseudo interference wave is applied to the biological tissue of the neck including the superior laryngeal nerve; an operation unit configured to adjust the current to be applied by the current application unit, to a sensory threshold at which the treated person becomes aware of the percutaneous stimulation; and a display unit configured to display index information based on the sensory threshold.

Abstract: A skin sensitivity improving agent which is safe and, when routinely taken or applied to the skin, exerts an effect of improving deterioration in peripheral sensation is provided. The present invention also provides a food, a drink, a feed or a cosmetic for improving sensation which exerts an effect of improving deterioration in peripheral sensation when orally taken or applied to the skin. The skin sensitivity improving agent includes, as the active ingredient, a basic protein fraction derived from milk or a degraded basic protein fraction derived from milk. By orally taking the basic protein fraction derived from milk or the degraded basic protein fraction derived from milk or applying the same directly to the skin, deterioration in sensation, in particular, peripheral sensation can be improved. Thus, a food, a drink, a feed or a cosmetic for improving sensation can be obtained.

Abstract: A deposition apparatus includes a deposition source; a rotatable dome provided with an opening which covers the source; a first lever provided outside of the dome; and a tray holder including a frame including a first rotating member and a rotating part including a second rotating member and being attached to the frame such that the rotating part rotates with the second rotating member around an axis supported by the frame. The rotating part includes work-holding trays arranged around the axis, the tray holder is installed on the dome such that a side of one of the trays covers the opening, the first rotating member is rotated by the first lever during rotation of the dome, and the second rotating member is rotated with the rotating part by the first rotating member so as to change the tray a side of which covers the opening to another one.

Abstract: The present invention provides a protein composition comprising a milk basic protein fraction; and at least one stabilizer selected from the group consisting of soybean polysaccharides, xanthan gum, pectin, gum arabic, gum ghatti, carrageenan, locust bean gum, sodium caseinate, lecithin, and carboxymethylcellulose. The protein composition significantly improves the heat resistance of the milk basic protein fraction. The present invention achieves heat treatment of a protein composition and food, beverage, feed, and pharmaceutical comprising such a protein composition at a temperature exceeding 90° C. without deactivation of the milk basic protein fraction.

Abstract: The invention relates to a fermented milk product includes angiogenin and/or angiogenin hydrolysate in an amount of 0.9 mg/100 g to 150 mg/100 g, and cystatin and/or cystatin hydrolysate in the mass ratio to the angiogenin and/or angiogenin hydrolysate of 0.006 to 1.7.

Abstract: The invention relates to a cheese includes angiogenin and/or angiogenin hydrolysate in an amount of 6.5 mg/100 g to 160 mg/100 g, and cystatin and/or cystatin hydrolysate in the mass ratio to the angiogenin and/or angiogenin hydrolysate of 0.02 to 1.6.

Abstract: The invention relates to a drink includes angiogenin and/or angiogenin hydrolysate in an amount of more than 0.8 mg/1.00 ml and not more than 150 mg/100 ml, and cystatin and/or cystatin hydrolysate in the mass ratio to the angiogenin and/or angiogenin hydrolysate of 0.006 to 1.7.